Akeso says its closely watched drug improved patient survival in a lung cancer trial
Posted:
Akeso, a Chinese biotech with a drug positioned to rival Merck’s megablockbuster Keytruda, has reported for the first time that the therapy can improve patient survival.
The number of doctors and experts that bridge the gap between university research and the NHS – translating discoveries into patient care – is "ageing and shrinking", the Academy of Medical Sciences has warned.
The UK's life sciences industry generated £146.9bn in…
A new machine learning tool developed by researchers at the Queensland Institute of Medical Research Berghofer can help pathologists identify subtle cancer biomarkers in standard tissue samples.
The tool, called STimage, applies spatial analysis to hematoxylin and eosin-stained (H&E) tissue…
Attendees
Sponsors and Exhibitors
Contact us